{{Rsnum
|rsid=7323267
|Gene=FOXO1
|Chromosome=13
|position=40629878
|Orientation=plus
|GMAF=0.1194
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=FOXO1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 38.9 | 58.4
| HCB | 0.0 | 6.6 | 93.4
| JPT | 0.0 | 1.8 | 98.2
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 7.0 | 93.0
| CHB | 0.0 | 6.6 | 93.4
| CHD | 0.0 | 12.0 | 88.0
| GIH | 5.0 | 39.6 | 55.4
| LWK | 0.0 | 0.9 | 99.1
| MEX | 5.2 | 43.1 | 51.7
| MKK | 0.0 | 1.3 | 98.7
| TSI | 5.9 | 23.5 | 70.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=19346957
|Title=Gene prioritization based on biological plausibility over genome wide association studies renders new loci associated with [[type 2 diabetes]].
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}